Apigenin

Apigenin demonstrates dose-dependent reduction of intestinal inflammatory markers in animal colitis models. Anxiolytic properties may reduce stress-related GI dysfunction.

Apigenin's GABA-A receptor activity is well-documented in binding assays and animal behavioral studies, supporting the traditional anxiolytic use of anise preparations. Estrogenic receptor binding confirmed at ER-β. Human bioavailability studies show significant plasma concentration after chamomile consumption (high apigenin content) suggesting absorption from anise tea is feasible. Clinical trials specifically for anise apigenin are lacking.

Apigenin is a widespread flavone in celery seed with robust clinical evidence for anti-inflammatory and antioxidant effects. Demonstrates analgesic properties in musculoskeletal pain and reduces inflammatory cytokine production in multiple cell types.

Apigenin is the primary anxiolytic compound in chamomile. Clinical trials show significant reduction in GAD-7 anxiety scores. Unlike full benzodiazepine agonists, apigenin produces anxiolysis without sedation or muscle relaxation at therapeutic doses.

One of the most studied dietary flavones. Anti-inflammatory, anxiolytic, and antispasmodic activity documented across cell, animal, and limited clinical studies.

Apigenin contributes to anxiolytic effects via GABA receptor modulation and may support androgen levels through aromatase inhibition.

Apigenin demonstrates anxiolytic effects in animal models via GABA-A receptor modulation — a pharmacological finding consistent with the calming effects attributed to chrysanthemum tea in TCM and folk tradition. Anti-inflammatory effects well-established. Human pharmacokinetic data available; bioavailability enhanced in glycoside forms. Potential drug interactions via CYP enzyme inhibition noted at high doses but considered clinically relevant only with sustained high-dose supplementation.

Apigenin is one of the most studied dietary flavonoids. Clinical trials demonstrate anti-anxiety effects without sedation at 50-100 mg doses. In vitro and animal studies show potent anti-inflammatory, hepatoprotective, and chemopreventive activity. Bioavailability is moderate and enhanced by gut microbiota metabolism.